Committee for Advanced Therapies (CAT) meeting with interested parties

EventHumanAdvanced therapiesInnovation

Date

Tuesday, 26 October 2021, All day

Location

Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

CAT engages in active dialogue with its interested parties on a regular basis. During its October 2021 annual meeting CAT and its interested parties discussed the following scientific topics: CAT activities, ATMP lifecycle support and patient access; comprehensiveness of clinical data in marketing authorisations; GMO/ERA in clinical trials and marketing authorisations; EMA-FDA parallel advice; The new HTA regulation; ATMPs and Real World Evidence. Other issues and questions from the participating interested parties were also addressed.

Documents

Share this page